Novo Nordisk will pay $200 million up front, with up to $1.8 billion in additional payments down the line, The Wall Street ...
The global needles market is projected to grow from USD 8.1 billion in 2024 to USD 14.7 billion by 2035, at a CAGR of 6.1%.
Semaglutide is already available in Ireland through diabetes medication Ozempic. However, its producer Novo Nordisk uses the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback